Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Expert Insights on Japanese Pharmaceutical Industry Trends

Despite being the second largest pharmaceutical market in 2008, Japan has experienced a lower growth rate than other major pharmaceutical markets, with the government’s imposed price control serving as a key contributing factor.

Get expert insights on:

  • M&A activity and overall consolidation in the Japanese pharmaceutical market
  • Market entry of generic manufacturers
  • Pricing and reimbursement in Japan
Engage an Expert on Japanese Pharmaceutical Industry ...

Gerson Lehrman Group Council Members are available to discuss Japanese Pharmaceutical Industry Trends via phone consultations, live meetings, surveys, and other custom GLG products and services.

Find, engage, and manageSM experts today through the GLG platform

Featured Council Members

GLG Council Members are leading experts including academics, scientists, and industry specialists

Nitin Naik, Vice President, FROST & SULLIVAN, INC

Nitin NaikWhat is a GLG Educator?|GLG Educators have qualified for GLG Member Programs and are therefore eligible to participate in ongoing in-depth consulting projects with GLG clients.

Vice PresidentFROST & SULLIVAN, INC

Patrick DeVillier, Sr. Director, Compliance, AP PHARMA, INC.

Patrick DeVillierWhat is a GLG Educator?|GLG Educators have qualified for GLG Member Programs and are therefore eligible to participate in ongoing in-depth consulting projects with GLG clients.

Sr. Director, ComplianceAP PHARMA, INC.

Peter Gensheimer, Director, SAVILLS JAPAN K.K.

Peter GensheimerWhat is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

DirectorSAVILLS JAPAN K.K.

Daniel Lintz, President & Chief Executive Officer, Safe Harbour Japan K.K.

Daniel LintzWhat is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

President & Chief Executive OfficerSafe Harbour Japan K.K.

Peter Culpepper, Chief Financial Officer, Provectus Pharmaceuticals, Inc.

Peter CulpepperWhat is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Chief Financial OfficerProvectus Pharmaceuticals, Inc.

Browse all 424 Leading Experts

Study Groups

Study groups are populations of experts knowledgeable on specific sub-topics within a broader industry

Study Group Name No. Members
Ophthalmologists (Japan) 10
Internal Medicine Physicians (Japan) 108
Obstetricians/Gynecologists (Japan) 11
Allergists (Asia) 13
Obstetricians/Gynecologists (Asia) 52

Browse all 974 Study Groups

Recent Live Meetings

Interactive roundtables, private visits, and small scale seminars are types of GLG Live Meetings

May 22, 2009 | Webcast

GLG Webcast: Consolidation Trends - China Pharma on May 22, 2009 at 7:30AM ET

December 2, 2009 | San Francisco

Seminar: Global Steel Update – Outlook for 2010 (San Francisco)

Browse all 278 Live Meetings

Recent News Analyses

News analyses are expert commentaries on current events, written by Council Members who are available for follow up consultations

Peplin merger with Leo pharma

November 19, 2009

Sunil Dhawan, Clinical Assistant Professor of Dermatology, STANFORD UNIVERSITY

Pharma Outsourcing: Where Will it End?

November 3, 2009

GLG Expert Contributor

Japan Consumer Finance Regulation Faces Final Hurdle

November 1, 2009

Daniel Lintz, President & Chief Executive Officer, Safe Harbour Japan K.K.

Japan Post President to Resign as DPJ Rolls Back Privatization Reforms

October 19, 2009

Daniel Lintz, President & Chief Executive Officer, Safe Harbour Japan K.K.

GSK's cervical cancer vaccine Cervarix gains approval in Japan

October 19, 2009

GLG Expert Contributor

Browse all 7849 GLG News Analyses

Contact Gerson Lehrman Group to engage a Japanese Pharmaceutical Industry Trends expert